Emerging hazard effects of proton pump inhibitor on the risk of colorectal cancer in low-risk populations: A Korean nationwide prospective cohort study

Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review

(2016) Jan T. Lowery et al.   CANCER

Pernicious anemia and colorectal cancer risk – A nested case–control study

(2016) Ben Boursi et al.   DIGESTIVE AND LIVER DISEASE

Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology

(2015) L. Lundell et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies

(2015) S. E. Attwood et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors: An Update

(2014) Ralph-Steven Wedemeyer et al.   DRUG SAFETY

Gastrin

(2014) Gemma Maddalo et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

Observations on the epidemiology of gastrointestinal and liver cancers in the Asia-Pacific region

(2014) Li-Yen GOH et al.   Journal of Digestive Diseases

Use of proton pump inhibitors correlates with increased risk of colorectal cancer in Taiwan

(2013) Shih-Wei Lai et al.   Asia-Pacific Journal of Clinical Oncology

Safety of Proton Pump Inhibitor Exposure

(2010) Yu–Xiao Yang et al.   GASTROENTEROLOGY

Colorectal cancer risk in relation to use of acid suppressive medications

(2009) Jessica Chubak et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Proton Pump Inhibitors and the Risk of Colorectal Cancer

(2008) Eva M. van Soest et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY